Delta 4
The AI engine Fit Assessment
BetaDelta 4 effectively utilizes machine learning for drug discovery, identifies new patterns in drug-disease relationships, and expands therapeutic options through drug repurposing.
Blurb
Delta 4 is a biotech startup driving the forefront of digital drug discovery and development.
HQ Location
Vienna (Austria)
Founded
2018
Employees
11 - 50
Total funding raised
Not available
Funding Status
Series A, April 7, 2021
Subspaces
- Drug Repurposing
- Drug Discovery Optimization
Delta4 is driving the forefront of digital drug discovery and development. We leverage a proprietary computational analytics platform "Hyper-C", combining straightforward biomedical testing and clinical validation of candidate drugs.
Our unique approach integrates iterative big data/in silico and experimental screens, offering the most efficient matching of clinical indications and compound/drug effects.